INCB018424 (ruxolitinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB018424 (ruxolitinib), covering 2015-03-23 to 2015-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis [Phase 2]